Medifast (MED) Other Non-Current Assets (2010 - 2026)

Medifast has reported Other Non-Current Assets for 17 years, with the latest figure at $6.9 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 21.47% year-over-year to $6.9 million; the trailing twelve-month figure through Mar 2026 stood at $6.9 million (down 21.47% YoY), and the FY2025 full-year result was $7.8 million, down 19.02% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $6.9 million, down from $7.8 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $15.8 million in Q3 2023, with the low at $6.9 million in Q1 2026.
• Historically, Other Non-Current Assets has averaged $11.4 million across 5 years, with a median of $12.0 million in 2022.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 286.44% — and 2025, when it tumbled 36.07%.
• Medifast's Other Non-Current Assets stood at $12.5 million in 2022, then climbed by 17.61% to $14.6 million in 2023, then plunged by 34.01% to $9.7 million in 2024, then dropped by 19.02% to $7.8 million in 2025, then retreated by 12.47% to $6.9 million in 2026.
• The last three Other Non-Current Assets figures came in at $6.9 million (Q1 2026), $7.8 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.